These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15506428)

  • 21. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
    Mullershausen F; Russwurm M; Friebe A; Koesling D
    Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alpha2beta1 isoform of guanylyl cyclase mediates plasma membrane localized nitric oxide signalling.
    Bellingham M; Evans TJ
    Cell Signal; 2007 Oct; 19(10):2183-93. PubMed ID: 17643962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Regulation of soluble guanylyl cyclase and its role in the treatment of cardiovascular diseases].
    Guan WL; Dou D; Gao YS
    Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):431-6. PubMed ID: 22363982
    [No Abstract]   [Full Text] [Related]  

  • 24. Nitric oxide/cyclic GMP-mediated signal transduction.
    Mayer B
    Ann N Y Acad Sci; 1994 Sep; 733():357-64. PubMed ID: 7526764
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide influences the maturation of cumulus cell-enclosed mouse oocytes cultured in spontaneous maturation medium and hypoxanthine-supplemented medium through different signaling pathways.
    Bu S; Xie H; Tao Y; Wang J; Xia G
    Mol Cell Endocrinol; 2004 Aug; 223(1-2):85-93. PubMed ID: 15279914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide signaling: systems integration of oxygen balance in defense of cell integrity.
    Gong L; Pitari GM; Schulz S; Waldman SA
    Curr Opin Hematol; 2004 Jan; 11(1):7-14. PubMed ID: 14676622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
    Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
    J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway.
    Francois M; Kojda G
    Neurochem Int; 2004 Nov; 45(6):955-61. PubMed ID: 15312990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide and cyclic guanosine monophosphate signaling in the eye.
    Murad F
    Can J Ophthalmol; 2008 Jun; 43(3):291-4. PubMed ID: 18443613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. cGMP signalling beyond nitric oxide.
    Mayer B; Koesling D
    Trends Pharmacol Sci; 2001 Nov; 22(11):546-8. PubMed ID: 11698077
    [No Abstract]   [Full Text] [Related]  

  • 31. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
    Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
    J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Sertoli cell tight junction dynamics in the rat testis via the nitric oxide synthase/soluble guanylate cyclase/3',5'-cyclic guanosine monophosphate/protein kinase G signaling pathway: an in vitro study.
    Lee NP; Cheng CY
    Endocrinology; 2003 Jul; 144(7):3114-29. PubMed ID: 12810568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NO, nitrotyrosine, and cyclic GMP in signal transduction.
    Hanafy KA; Krumenacker JS; Murad F
    Med Sci Monit; 2001; 7(4):801-19. PubMed ID: 11433215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A; Sarkar G; Etgen AM
    J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble guanylate cyclases in the retina.
    Sitaramayya A
    Mol Cell Biochem; 2002 Jan; 230(1-2):177-86. PubMed ID: 11952093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern.
    Michelakis ED
    Eur Respir J; 2009 Apr; 33(4):717-21. PubMed ID: 19336588
    [No Abstract]   [Full Text] [Related]  

  • 39. Consideration of natriuretic peptide receptor C.
    Hamilton EJ; Figtree GA; Rasmussen HH
    Circ Res; 2011 Feb; 108(4):e4; author reply e5. PubMed ID: 21335426
    [No Abstract]   [Full Text] [Related]  

  • 40. [Guanylate cyclases: physiological processes mediated by cyclic GMP].
    Rivero-Vilches F; de Frutos S; Rodríguez-Puyol M; Rodríguez-Puyol D; Saura M
    Nefrologia; 2001; 21(3):233-9. PubMed ID: 11471303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.